Abstract
The eighth edition Guide for the Care and Use of Laboratory Animals sets standards for diverse laboratory animal care and use practices. It frames its standards as performance, engineering, and practice standards, with a strong emphasis on performance standards, allowing for multiple routes to clearly defined outcomes. Standards intended to be upheld rigorously are indicated through the use of must in the description, and those accommodating more flexibility are indicated through may and should statements. With respect to pain management standards, a fourth type of standard—the jurisdictional standard—has been prevalent through all 8 editions of the Guide. Under jurisdictional standards, specific methods and outcomes for measuring, preventing, or alleviating pain are not detailed, but the various jurisdictions of veterinarian, investigator, and IACUC are elaborated. Although data on pain management in laboratory animals has expanded greatly since the 1996 Guide, the eighth (2011) edition does not contain major new standards or guidance regarding animal pain management. Requirements for veterinary and IACUC involvement remain as in prior editions, and the duty of veterinarians and scientists to stay abreast of new developments is expected to drive refinement of animal pain management institution by institution. The current article details selected specific pain management standards in the 2011 Guide, lists topics in pain management for which the Guide does not set clear standards, and suggests possible standards for those topics.
Abbreviation: OLAW, Office of Laboratory Animal Welfare
First published in 1963 as the Guide for Laboratory Animal Facilities and Care,5 the Guide for the Care and Use of Laboratory Animals (the Guide) has since served as a reference on laboratory animal care and use throughout the world. Two panels of 31 experts spent more than 2 years in producing the eighth edition28 for publication in 2011. This serious effort reflects the equally serious role of the Guide: for funded institutions, the United States Public Health Service “requires institutions to use the Guide as a basis for developing and implementing an institutional program for activities involving animals,”34 whereas AAALAC uses the Guide as one of 3 primary standards for assessing institutions for accreditation. The Office of Laboratory Animal Welfare (OLAW) and AAALAC have both posted guidance on how they will use this new edition of the Guide to review compliance and the timetable according to which compliance is expected.7,16
The Guide serves several partially overlapping roles, providing veterinary and technical information, management recommendations, ethical norms, and regulatory requirements (for recipients of funds from the United States Public Health Service). During the updating process preceding each new edition of the Guide, the authoring committee of content experts, most of whom are laboratory animal veterinarians, review the available scientific information about laboratory animals, prioritizing peer-reviewed scientific publications. These reviewers determine what new information about laboratory animals has been established since the previous Guide and use their practical experience to suggest how this new factual information should inform practices in a research institution. A second role of the Guide is recommending institutional arrangements and personnel policies that its authors believe, based not on scientific study but on other factors, will work best. A third role of the Guide is to set ethical norms. A fourth is to set regulatory standards, the minimal expectations that institutions will be required to meet for funding from the Public Health Service and the standards by which AAALAC will assess institutions that voluntarily seek its accreditation. All of these roles—technical, managerial, ethical, and regulatory—are in the current Guide’s discussions of animal pain management.
The Public Health Service mandate to minimize laboratory animal pain is clear: “Procedures with animals will avoid or minimize discomfort, distress, and pain to the animals.”14 Its application, however, is complicated, because ‘minimize’ does not equal or imply ‘eliminate.’ Laboratory animals risk significant pain from surgical manipulations, induced or spontaneous cancers, diseases due to their genetic makeup, and other causes. Pain in animals may be undertreated if it is not recognized, whether because of poor training, overnight periods without pain assessments, or a lack of information on signs of pain in a given species, strain, age, or situation. Pain may be undertreated for lack of effective, safe analgesics, or for poor timing, dose, or frequency of administration. Competing concerns, especially those regarding the potential for confounding effects of pain management practices on research data, may lead to animals receiving less than complete pain alleviation.12,30 Clearly articulated standards can guide efforts at animal welfare and allow assessment of the pain management program by oversight bodies.
Because of its importance and complexity, animal pain management is a major component of any laboratory animal care and use program. Animal pain was addressed in the first edition of the Guide, although only as a component of postsurgical care, and has been addressed in each subsequent edition.5 In companion animal veterinary practice, patient pain management can be technically challenging but ethically clear, with little argument for leaving patient pain untreated. Veterinarians must recommend and prescribe the maximal pain relief that is safe for their patients, within the constraints of client compliance and controlled substance regulations.23 However, the situation is different in the laboratory. Because research procedures can cause pain and because both pain and the analgesics that treat it can affect research outcomes, pain management of laboratory species has never been as simple as obtaining a veterinarian's prescription for the best analgesic for the animal. Animal comfort is balanced against research needs. Balancing the research needs and animal welfare requires factual information, ethical judgment and, for difficult cases, clear rules on who makes the final decision.
Compliance with the Guide is required of institutions that receive funds from the Public Health Service and is assured through several routes.14 Institutions that have filed an Animal Welfare Assurance with OLAW self-report annually their compliance with the Guide. Their IACUC, veterinarians, researchers, and Institutional Official interpret the Guide to the best of their abilities, with guidance available from OLAW. Onsite compliance audits from OLAW are rare. Institutions might therefore vary broadly in their decisions on details that are not clearly articulated in the Guide. Some institutions voluntarily seek accreditation through AAALAC. Site visitors scrutinize a program in great detail and bring a cross-institutional perspective that carries the potential for increasing standardization among institutions.
Understanding an institution's pain-management requirements as based on recommendations in the Guide requires understanding the different levels of commitment and different types of standards in the Guide. Standards are norms that prescribe, recommend, or prohibit some behavior and are based simultaneously on factual information and ethical values, although not every statement of standards will make the facts or values explicit.11
The Guide (on page 8) distinguishes its must, should, and may statements and discusses what weight each carries.12 Institutions need to self-assess their compliance with all of the must statements and most of the should statements. AAALAC also looks closely at this distinction.7,9 May, is, and can statements are numerous within the Guide and are to be read as “suggestions to be considered” (p 8).12 These can be the authors’ preferred way in some circumstances to meet a stated performance goal. In addition, may and is statements have been harbingers of future editions’ should statements. For example, whereas the seventh edition of the Guide indicated that “Nonpharmacologic control of pain is often effective,”21 the eighth edition writes, “Nonpharmacologic control of pain . . . should not be overlooked” [emphasis added].28 It is too early to say what weight AAALAC or OLAW will attach to this upgrade to should.
The eighth Guide echoes the United States government's distinction between engineering and performance standards, emphasizing flexibility and professional judgment. In American policy, as explained by the United States Office of Management and Budget circular A19,35 the difference between performance and engineering (or prescriptive, or design) standards is not how forcefully compliance is required but rather the route to compliance. A performance standard “states requirements in terms of required results with criteria for verifying compliance but without stating the methods for achieving required results.”35
In service of the goal that animals experience no pain or distress during surgery, one could write a performance standard for surgical anesthesia, for example, that animals be anesthetized to the point of areflexia to noxious stimuli. By contrast, an engineering standard might specify a particular anesthetic and dose. Performance can be verified in real time by testing the animal's reflexes or later by reviewing anesthetic notes on patient response. Compliance with the engineering standard is verified by reviewing drug records. In this hypothetical example, the performance standard gives greater flexibility in meeting the goal of pain-free surgery. To the extent that anesthetic doses that abolish reflexes may be far higher than what is necessary to abolish pain, using areflexia as the standard risks overanesthetizing the patient, but is nonetheless clear and measureable.6 Using an engineering standard facilitates assessment of compliance but reduces both flexibility and assurance that the goal is actually being met for the individual patient. The key issue is not whether the patient received the prescribed dose, but whether the administered dose safely abolished intraoperative pain.
As with surgical anesthesia, so too with postsurgical analgesia, although measuring painfulness in conscious animals may be more complicated than is measuring reflexes in anesthetized patients. An engineering standard might state specific drugs and dosages for a given species and a given procedure. A performance standard might state the parameters to be monitored and at what frequency and set a criterion for just how pain-free (on a given scale) an animal must be, leaving choice of analgesic flexible.
The Guide contains both engineering and performance standards, emphasizing the importance of flexibly met performance standards. But the Guide also includes what I call jurisdictional standards. 10 A recurring practice since the first edition of the Guide has been to supplement technical animal-specific information with recommendations on who in an institution should have authority or jurisdiction on various issues. Related to the jurisdictional standards are procedural recommendations and standards, such as what issues the IACUC should review in an animal use protocol (p 25–27).
The eighth edition of the Guide also has introduced, on pages xiv and 7, what it labels as practice standards. It does not provide specific examples, and the concept will require development, as OLAW and AAALAC develop and post their guidance on how to comply with these aspects of the eighth edition of the Guide.33 Reference to practice standards seems to allow for and to require that professionals remain abreast of emerging information and that they apply this information to their facilities. However, the concept as described mostly seems to be an explanation that the performance and engineering standards listed in the current Guide come not just from published literature but also from experts’ experience. The concept of practice standards in the eighth edition of the Guide is not sufficiently clear currently to formulate specific guidance to facilities in preparing for accreditation site visits.
Standards of Animal Pain Management in the Guide
What are the current Guide’s standards of animal pain management, and how can AAALAC or IACUC assess compliance? Figure 1 lists several standards regarding animal pain management; some overlap with the management of distress, whereas others are focused more specifically on pain. Readers expecting specific guidance on pain recognition, prevention, or management will not find them in the Guide. There are no tables of recommended drugs and dosages comparable to those for cage size and ambient temperature. Whereas Chapter 3 specifies clear measureable performance criteria for cage size (for example, on page 56, that “at a minimum, animals must have enough space to express their natural postures and postural adjustments without touching the enclosure walls or ceiling, . . .”), there is nothing similar with respect to pain. The standards tilt instead primarily—but not exclusively—to the jurisdictional, mostly without defined or measureable performance criteria.
Jurisdictional standards.
The eighth edition of the Guide continues principles that have been maintained throughout previous editions, placing pain management squarely in the realm of veterinary medical care (and thereby requiring every institution to have at least a part-time veterinarian). After passage of the 1985 Health Research Extension Act,21 the seventh issue of the Guide updated how IACUC, veterinarians, and investigators interact. The current issue of the Guide continues to consider protocol-associated pain management a component of veterinary medical care (p 120), although it is the IACUC, not the veterinarian, that approves a protocol and its pain management provisions. However, when the approved protocol leads to more pain or distress than anticipated, the investigator must contact the veterinarian (p 5).
A new provision under Emergency Care in the eighth edition of the Guide (p 114) stipulates that in an animal health emergency when the investigator is not available, the veterinarian must have authority “delegated by senior administration” to treat an animal in need. Of note, this emergency veterinary authority extends to situations when the principal investigator is available but is not in consensus with the veterinarian on the appropriate treatment. This expansion of the veterinarian's authority (and moreover, this recognition that such disagreements can arise) is new to the current Guide. This expanded authority of the veterinarian does not presently extend outside of emergency situations, where the IACUC retains its authority. Based on components of the current Guide, AAALAC's new Program Description form for accreditation specifically asks what authority the Attending Veterinarian has for handling animal emergencies.9
Other personnel issues: training and qualifications.
Staff training has been a concern since the first edition of the Guide. The eighth edition of the Guide continues this theme with no significant changes, highlighting that it is essential (which seems stronger than must) that people caring for animals be trained on recognizing species-specific and individual indicators of wellbeing (p 121). Site visitors could assess this need as an engineering standard (by looking at training records) or as a performance standard (by observing outcomes and determining whether poor outcomes reflect insufficient training).
Sources of external guidance.
In addition to referencing specific laws that must be abided, the Guide points readers to other sources of guidelines (which may meet the definition of ‘practice standards’), such as those for biosafety concerns and animal euthanasia, that should or must be followed.4,13,14 AAALAC underscores these documents’ importance by listing them in its Reference Resources for accreditation.7 In its discussions of pain, the current edition of the Guide references several documents, including the National Research Council's 2009 Recognition and Alleviation of Pain in Laboratory Animals,15 as sources of information. None of these is listed as a document that should or must be consulted, nor is the National Research Council report one of AAALAC's posted reference resources. Therefore, institutions may have considerably more flexibility in setting standards in loco, with the potential for increased interinstitutional variability in animal pain management. Institutions may differ widely in their expectation of preemptive postsurgical analgesia, in allowing various procedures (for example, tissue collection for genotyping) without anesthesia, or in their practices for permitting withholding of analgesics during painful procedures, and yet all might be compliant with the eighth edition of the Guide.
Ethical positions.
The Guide has long included various normative, ethical positions that cannot be derived from science alone. In 1972, the fourth edition of the Guide highlighted multiple major survival surgeries in the same animal (except when a necessary part of a single project) for special prohibition, specifying what might constitute adequate ethical justification (for example, “conserving members of a rare species”) and what would not (“cost alone”).24 The current Guide continues this ethical prohibition, adding the requirement for special permissions from the USDA or IACUC and keeping the commitment of monitoring how animals are faring “through continuing evaluation of outcomes” (p 30). On this subject, the current Guide has updated its standard of what constitutes a “major” surgery, combining performance criteria (including the potential for postoperative pain [p 117]) with a jurisdictional assignment (IACUC and veterinarian [p 30]) to replace older, more rigid definitions that could either under- or overscore how ‘major’ a procedure might be to the animal. Surgeries that previously were classed as minor might now be classed as major and vice versa.
The issue of when to allow multiple surgery is a subset of a broader long-running ethical concern in laboratory animal use: the balance of refinement compared with reduction of animal numbers.40,41 The current Guide updates its stance on this issue, urging less intensive use of more animals rather than more intensive use of fewer animals: “Principal investigators are strongly discouraged from advocating animal reuse as a reduction strategy, and reduction should not be a rationale for reusing an animal or animals that have already undergone experimental procedures, especially if the well-being of the animals would be compromised” (p 5). This norm could apply to surgical or nonsurgical uses. The Guide generally has not explained its reasoning on these issues in depth, but in this balance of numbers compared with harm-per-animal, scientific reasoning is less likely at play than are basic ethical principles, such as fairness.
Technical guidance.
The Guide does contain some specific recommended or required practices, although the jurisdictional recommendations nonetheless predominate. Compared with the level of detail in the Environment, Housing, and Management chapter, for example, detailed technical recommendations on pain management are sparse. Veterinarians are expected to stay current with evolving information and standards of care, as presented in emerging research studies, at conferences and symposia, and in assorted textbooks.1-3,17-20,22 If they look to the Guide for technical or medical guidance on veterinary practice for pain management, they will learn that: (1) the use of balanced anesthesia, including intraoperative analgesics, can minimize physiologic fluctuations during surgery (p 119; new to the eighth edition of the Guide); (2) pain is assessed by behaviors, which may vary with species (p 120); (3) pre- or intraoperative preemptive analgesia reduces postoperative pain (p 121); (4) analgesics may be either systemic or local (p 121; new to the eighth edition of the Guide); (5) patches and slow-release pumps may be useful for some chronic pain (p 122; new to the eighth edition of the Guide); and (6) painful stimuli can return a lightly anesthetized animal to consciousness, that antinociceptive doses of anesthetics are required to prevent this, and that checking a single reflex response may be insufficient to assess this (p 122; new to the eighth edition of the Guide). Some of these can and is statements have associated should statements in the current edition of the Guide. Others (for example, discussions of balanced anesthesia, preemptive analgesia, and the use of patches and pumps for long-term analgesia) do not have the status of should in the current edition.
So what should institutions do to stay compliant with the Guide regarding pain management? In addition to some long-standing general principles (for example, adequate training, assuming that what is painful in people might be painful to animals) and the jurisdictional commitments noted earlier: (1) animals should be monitored for postoperative pain, for infection, and for return to function (intake, elimination; p 120); (2) postoperative monitoring should include wound management and timely removal of sutures, clips, or staples (p 120); (3) animals should be monitored for pain even after administration of pain medicines and should receive additional pain treatment if necessary (p 122; new to the eighth edition of the Guide); (4) nonpharmacologic pain management strategies should be considered (p 122; new to the eighth edition of the Guide); (5) antinociceptive depth of anesthesia must be checked prior to starting surgery (p 122; new to the eighth edition of the Guide); and (6) anesthetic doses should first be defined by doing a procedure without paralyzing agents before doing it with muscular blockade (p 123).
The preface to the eighth edition of the Guide preface notes increased coverage of intraoperative monitoring (p 119) and that readers are advised to read and interpret, looking for the implied should. Because routine monitoring of blood pressure and even respiratory rates is difficult in mice and is all but impossible with fish or frogs, professional judgment is necessary. That said, the current Guide promotes a higher standard of intraoperative care than used previously, with its emphases on maintaining body temperature, replacement of fluid losses, and more extensive monitoring than those indicated through the less specifically worded “physiological function . . . and clinical signs” of the seventh edition of the Guide.27
The current issue of the Guide has likewise greatly expanded the discussion of humane endpoints as a strategy for limiting animal pain and distress. The emphasis is on defining endpoints early in the process (during protocol development), as a collaboration among veterinarian, principal investigator, and IACUC (p 27–28). Pilot studies are recommended for some situations, as are recommended readings on setting appropriate endpoints. Models most likely to require endpoint-setting are listed (p 27) with a general suggestion that physical or behavioral deficits or tumor size might serve as endpoints (p 123); more specific technical design or performance standards (for example, tumor diameter of 2 cm or greater or a tumor that interferes with mobility) are not provided.
Guidance on Specific Facets of Animal Pain Management
Despite the expanded coverage, especially in details on anesthetic monitoring and setting endpoints, and despite specific jurisdictional recommendations on management of perioperative and chronic pain, the eighth edition of the Guide has relatively little content on the technical and veterinary aspects of animal pain management. This limited content may reflect a lack of available information or professional and cross-institutional consensus on best practice, with a belief that the Guide’s should not drive minimal standards. The following sections discuss some aspects of pain management that are not covered extensively in the Guide.
Chronic pain.
Chronic pain is a serious concern in laboratory animal medicine. This pain may be the direct result of studies of chronic pain or may accompany spontaneous arthritides, cancers, or other natural illnesses. Contingent pain that is caused by experiments (for example, cancer studies) but is not a necessary or intended part of the experiment is a significant welfare problem.
Moderate chronic pain can be challenging to diagnose. Cancer, joint, and other chronic pains in human and nonhumans are often refractory to analgesic treatments.29 Moreover, if the experiment itself is the source of the pain, pain management strategies that do not negatively interfere with the study are required. The eighth edition of the Guide and the National Research Council's Recognition and Alleviation of Pain in Laboratory Animals15 agree that monitoring for the earliest possible endpoints is crucial, but in the face of myriad models that may cause chronic pain, both publications stop short of setting specific design or performance standards.
The current Guide mentions 2 possibilities for analgesic management of chronic pain: transdermal opiate patches and implantable osmotic pumps containing analgesics (p 122). At present, this one-sentence mention seems arbitrary in highlighting these 2 modalities and is of limited use. Other considerations include size limitations (opiate patches that are suitable for small rodents are not presently available), slow-release NSAID or lidocaine patches, issues related to the need for multiple surgeries to place and replace osmotic pumps, the availability of oral pain medications for long-term use, and consideration of the negative effects of pain and analgesics on animal health and on some types of research, whether from chronic pain or from the available treatments
Category E studies.
Studies that are reported in column E on annual USDA reports (that is, studies for which the IACUC approves withholding of pain management in animals that will undergo more than minor or momentary pain or distress) generate major animal welfare concerns. The same issues arise for non-USDA-regulated animals, even if study is not designated as category E. Category E studies are not limited to pain research but may include a wide range of cancer, toxicology, inflammatory, or infectious disease research. The fourth and fifth editions of the Guide had clear and simple jurisdictional statements indicating that if such studies must be done, they must be directly supervised by the responsible investigator.24,25 The sixth edition of the Guide added the requirement for committee approval.26 The seventh and eighth editions of the Guide, despite their expanded discussions of what IACUC review, are not explicit regarding whether category E studies must be reviewed or might be approved. Therefore, clear guidance—be it ethical, jurisdictional, or technical—is presently unavailable.
The National Research Council's publication on pain15 emphasizes that pain itself, not just analgesics, can cause unwanted variability in research data. Therefore a reasonable standard for approval of category E studies might be the requirement for a literature search for the effects of both pain and analgesics on the model. Such literature searches might generate no useful information, but this suggested standard coupled with more comprehensive reporting of animal research,29,31 could influence publication practices. An IACUC must determine how to proceed if necessary information on effects of pain and pain treatments is incomplete or not provided. A model-by-model review, suggesting which analgesics are acceptable and which are disruptive, could be helpful but likely would require far more detail than the Guide could include. Currently, institutions may vary greatly in what they consider to be a category E study and in what justification is necessary for its approval.
For euthanasia (as called for in Public Health Service Policy14) and for biosafety, the Guide sets standards by referring to other expert documents. The National Research Council publication on pain15 could serve this role with regard to pain. The document contains some fairly explicit standards,15 including that (1) analgesic use should be timed so that effective plasma levels are achieved when nociceptive barrage is greatest (p 72); (2) untreated pain should not be used to restrain animals from moving and injuring themselves postoperatively (p 76); (3) postoperative pain management should not rest solely on the residual effects of intraoperative anesthetics with analgesic effects (p 76); (4) analgesics should be excluded from studies of inflammation only if other factors that affect inflammation or immunity are well controlled (p 89); and (5) standard manipulations and husbandry procedures should be modified for hyperalgesic animals in chronic pain to less painful procedures (p 97).
Conclusion
In the 14 y since the publication of the seventh edition of the Guide, the literature on laboratory animal pain detection and treatment has grown. Veterinary standards of practice for pain management have evolved.1-3,23 The effects of pain and of analgesics on various research models have been investigated and published (for example, in studies of tumor metastasis).32,37-39 The eighth edition of the Guide reflects this evolution indirectly by emphasizing that veterinarians and scientists must stay current with this literature rather than by providing specific updated medical or technical standards. Few explicit new commitments for pain management are detailed in the current Guide, beyond expanded consideration of humane endpoints. To comply with the new Guide, institutions already familiar with the jurisdictional standards of the seventh edition of the Guide, with its requirements for IACUC oversight and veterinary input, may require implementation of expanded veterinary authorization for management of emergencies but will otherwise be well situated to comply with the guidelines and mandates of the current Guide. The resource Recognition and Alleviation of Pain in Laboratory Animals15 supplements the factual guidance provided in the eighth edition of the Guide and includes expert recommendations of standards that an IACUC (or the ninth edition of the Guide) might adopt.
Acknowledgments
The author thanks Keith Anderson, Diana Bauer, Krista Lindstrom, Clifford Roberts, Jerry Silverman, David Takacs, and 3 anonymous JAALAS peer reviewers for critical assistance in writing this paper.
References
- 1.American Animal Hospital Association [Internet]. Analgesics position statement. [Cited 14 August 2011]. Available at: http://www.aahanet.org/Library/Analgesics.aspx
- 2.American College of Laboratory Animal Medicine [Internet]. Guidelines for the assessment and management of pain in rodents and rabbits. [Cited 15 August 2011]. Available at: http://www.aclam.org/Content/files/files/Public/Active/position_pain-rodent-rabbit.pdf
- 3.American College of Veterinary Anesthesiologists 1998. American College of Veterinary Anesthesiologists’ position paper on the treatment of pain in animals. J Am Vet Med Assoc 213:628–630 [PubMed] [Google Scholar]
- 4.American Veterinary Medical Association [Internet]. 2007. AVMA guidelines on euthanasia, 2007 update. [Cited 15 August 2011]. Available at: http://www.avma.org/issues/animal_welfare/euthanasia.pdf
- 5.Animal Care Panel 1963. Guide for laboratory animal facilities and care. Washington (DC): Public Health Service [Google Scholar]
- 6.Antognini JF, Barter L, Carstens E. 2005. Overview movement as an index of anesthetic depth in humans and experimental animals. Comp Med 55:413–418 [PubMed] [Google Scholar]
- 7.Association for the Assessment and Accreditation of Laboratory Animal Care International [Internet]. AAALAC's approach to implementing the new ILAR Guide. [Cited 14 August 2011]. Available at: http://www.aaalac.org/about/AAALAC_International_Approach_to_Implementing_the_New_Guide.pdf
- 8.Association for the Assessment and Accreditation of Laboratory Animal Care International [Internet]. AAALAC's reference resources. [Cited 10 August 2011]. Available at: http://www.aaalac.org/accreditation/resources.cfm
- 9.Association for the Assessment and Accreditation of Laboratory Animal Care International [Internet]. Program description animal care and use program (form). [Cited 10 August 2011]. Available at: http://www.aaalac.org/programdesc/Program_Description_2011.doc
- 10.Carbone L. 2004. What animals want: expertise and advocacy in laboratory animal welfare policy. New York (NY): Oxford [Google Scholar]
- 11.Carbone L. 2010. Expertise and advocacy in animal-welfare decision making: considerations for a veterinary curriculum in animal welfare. J Vet Med Educ 37:36–39 [DOI] [PubMed] [Google Scholar]
- 12.Carbone L. 2011. Pain in laboratory animals: the ethical and regulatory imperatives. PLoS ONE 6:e21578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Centers for Disease Control and Prevention and National Institutes of Health Biosafety in microbiological and biomedical laboratories, 5th ed. Washington (DC): Department of Health and Human Services [Google Scholar]
- 14.Committee on Occupational Safety and Health in Research Animal Facilities, Institute for Laboratory Animal Research, National Research Council, National Research Council 1997. Occupational health and safety in the care and use of research animals. Washington (DC): National Academy Press. [Google Scholar]
- 15.Committee on Recognition and Alleviation of Pain in Laboratory Animals, National Research Council 2009. Recognition and alleviation of pain in laboratory animals. Washington (DC): National Academies Press; [PubMed] [Google Scholar]
- 16.Department of Health and Human Services, National Institutes of Health 2011. Laboratory animal welfare: adoption and implementation of the eighth edition of the Guide for the Care and Use of Laboratory Animals. Fed Regist 76:74803 [Google Scholar]
- 17.Fish RE, Brown MJ, Danneman PJ, Karas AZ. 2008. Anesthesia and Analgesia in Laboratory Animals, 2nd Edition. London: Academic Press, Elsevier [Google Scholar]
- 18.Flecknell P. 2009. Laboratory Animal Anaesthesia, Third Edition. London: Academic Press [Google Scholar]
- 19.Flecknell P, Waterman-Pearson A. 2000. Pain Management in Animals. Edinburgh: Saunders [Google Scholar]
- 20.Gaynor JS, Muir WW, III, 2009. Veterinary Pain Management, 2nd edition. St. Louis, (MO): Mosby Elsevier [Google Scholar]
- 21. Health Research Extension Act of 1985. PL 99-158. Animals in research. [PubMed]
- 22.Hellebrekers LJ, 2000. Animal Pain. Utrecht: van der Wees [Google Scholar]
- 23.Hellyer P, Rodan I, Brunt J, Downing R, Hagedorn JE, Robertson SA. 2007. AAHA–AAFP pain management guidelines for dogs and cats. J Feline Med Surg 9:466–480 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Institute of Laboratory Animal Resources 1972. Guide for the care and use of laboratory animals. Bethesda (MD): National Institutes of Health [Google Scholar]
- 25.Institute of Laboratory Animal Resources 1978. Guide for the care and use of laboratory animal resources. Bethesda (MD): National Institutes of Health [Google Scholar]
- 26.Institute of Laboratory Animal Resources 1985. Guide for the care and use of laboratory animals. Bethesda (MD): National Institutes of Health [Google Scholar]
- 27.Institute of Laboratory Animal Resources 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press [Google Scholar]
- 28.Institute for Laboratory Animal Research 2011. Guide for the care and use of laboratory animals, 8th ed. Washington (DC): National Academies Press [Google Scholar]
- 29.Institute for Laboratory Animal Research 2011. Guidance for the description of animal research in scientific publications. Washington (DC): National Academies of Sciences; [PubMed] [Google Scholar]
- 30. Karas AZ. 2006. Barriers to assessment and treatment of pain in laboratory animals. Lab Anim (NY) 35:38–45 [DOI] [PubMed] [Google Scholar]
- 31.Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. 2010. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Moudgil GC, Singal DP. 1997. Halothane isoflurane enhance melanoma tumour metastasis in mice. Can J Anaesth 441: 90-94 [DOI] [PubMed] [Google Scholar]
- 33.NIH Office of Laboratory Animal Welfare [Internet]. Frequently asked questions: PHS policy on humane care and use of laboratory animals. [Cited 15 August 2011]. Available at: http://grants.nih.gov/grants/olaw/faqs.htm
- 34.Office of Laboratory Animal Welfare, National Institutes of Health 2002. Public Health Service policy on humane care and use of laboratory animals. Bethesda (MD): Department of Health and Human Services [Google Scholar]
- 35.Office of Management and Budget [Internet]. Memorandum for heads of executive departments and agencies: federal participation in the development and use of voluntary consensus standards and in conformity assessment activities. Circular no. A-119, revised. [Cited 15 June 2011]. Available at: http://standards.gov/standards_gov/a119.cfm
- 36.Pacharinsak C, Beitz A. 2008. Animal models of cancer pain. Comp Med 58:220–233 [PMC free article] [PubMed] [Google Scholar]
- 37.Page GG, Blakely WP, Ben-Eliyahu S. 2001. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 90:191–199 [DOI] [PubMed] [Google Scholar]
- 38.Sasamura TS, Nakamura S, Iida Y, Fujii H, Murata J, Saiki I, Nojima H, Kuraishi Y. 2002. Morphine analgesia suppresses tumor growth metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol 441:185–191 [DOI] [PubMed] [Google Scholar]
- 39.Shavit YS, Ben-Eliyahu S, Zeidel A, Beilin B. 2004. Effects of fentanyl on natural killer cell activity on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 11:255–260 [DOI] [PubMed] [Google Scholar]
- 40.Silverman J. 2010. Justifying multiple survival surgeries. Lab Anim (NY) 39:201. [DOI] [PubMed] [Google Scholar]
- 41.Silverman J. 2011. ‘Doubling up’ procedures in a protocol amendment. Lab Anim (NY) 40:209. [DOI] [PubMed] [Google Scholar]